WO1997010211A1 - Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant - Google Patents
Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant Download PDFInfo
- Publication number
- WO1997010211A1 WO1997010211A1 PCT/FR1996/001416 FR9601416W WO9710211A1 WO 1997010211 A1 WO1997010211 A1 WO 1997010211A1 FR 9601416 W FR9601416 W FR 9601416W WO 9710211 A1 WO9710211 A1 WO 9710211A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- alkyl
- hydrogen
- substituted
- unsubstituted
- Prior art date
Links
- 0 CCCCCCC[C@]1(CC2)*2CCC1 Chemical compound CCCCCCC[C@]1(CC2)*2CCC1 0.000 description 8
- LOHSIDYDRYHISC-UHFFFAOYSA-N CCCC(CCN)CN Chemical compound CCCC(CCN)CN LOHSIDYDRYHISC-UHFFFAOYSA-N 0.000 description 1
- XPXWYVCQCNFIIJ-UHFFFAOYSA-N Cc1nnc(N)[o]1 Chemical compound Cc1nnc(N)[o]1 XPXWYVCQCNFIIJ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT96931126T ATE254104T1 (de) | 1995-09-14 | 1996-09-13 | 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidin derivate als für den menschlichen nk3-rezeptor selektive antagonisten |
JP9511718A JPH11514983A (ja) | 1995-09-14 | 1996-09-13 | 新規なヒトnk▲下3▼受容体選択的拮抗性化合物、これらを得るための方法、及びこれらを含有する薬学的組成物 |
AU69925/96A AU6992596A (en) | 1995-09-14 | 1996-09-13 | Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
MX9801890A MX9801890A (es) | 1995-09-14 | 1996-09-13 | Nuevos compuestos antagonistas selectivos del receptor nk3 humano, procedimiento para su obtencion y composiciones farmaceuticas que los contienen. |
DE69630717T DE69630717T2 (de) | 1995-09-14 | 1996-09-13 | 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidinderivate als für den menschlichen nk3-rezeptor selektive antagonisten |
EP96931126A EP1019373B1 (fr) | 1995-09-14 | 1996-09-13 | Derives de 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine comme antagonistes selectifs du recepteur nk3 humain |
US09/043,247 US6028082A (en) | 1995-09-14 | 1996-09-13 | Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
BR9610081A BR9610081A (pt) | 1995-09-14 | 1996-09-13 | Composto solvatos processo para preparação de um composto enantiômero e composição farmacêutica |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9510776A FR2738819B1 (fr) | 1995-09-14 | 1995-09-14 | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
FR95/10776 | 1995-09-14 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/043,247 A-371-Of-International US6028082A (en) | 1995-09-14 | 1996-09-13 | Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
US09/437,203 Division US6291672B1 (en) | 1995-09-14 | 1999-11-09 | Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997010211A1 true WO1997010211A1 (fr) | 1997-03-20 |
Family
ID=9482536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1996/001416 WO1997010211A1 (fr) | 1995-09-14 | 1996-09-13 | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
Country Status (11)
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998011090A2 (en) * | 1996-09-16 | 1998-03-19 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
WO1998031364A1 (en) * | 1997-01-21 | 1998-07-23 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
WO1999038514A1 (en) * | 1998-02-02 | 1999-08-05 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
US6040316A (en) * | 1996-09-16 | 2000-03-21 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
EP0992493A1 (en) * | 1998-10-08 | 2000-04-12 | Pfizer Inc. | Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists |
WO2000021931A1 (fr) * | 1998-10-09 | 2000-04-20 | Sanofi-Synthelabo | Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk3 humains |
WO2000035879A1 (fr) * | 1998-12-15 | 2000-06-22 | Sanofi-Synthelabo | Derives de 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide et leur procede de preparation |
WO2000039126A1 (fr) * | 1998-12-23 | 2000-07-06 | Sanofi-Synthelabo | Procede de preparation du (r)- (+)-3-{1-[2- (4-benzoyl-2- (3,4-difluorophenyl)morpholin-2- yl)ethyl]-4-phenylpiperidin-4- yl}-1,1- dimethyluree, de ses sels, solvats et/ou hydrates |
US6124319A (en) * | 1997-01-21 | 2000-09-26 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
WO2000061125A2 (fr) * | 1999-04-13 | 2000-10-19 | Sanofi-Synthelabo | L'osanetant dans le traitement des troubles de l'humeur |
US6140349A (en) * | 1998-02-02 | 2000-10-31 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
FR2824828A1 (fr) * | 2001-05-21 | 2002-11-22 | Sanofi Synthelabo | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
WO2005016884A1 (en) | 2003-08-15 | 2005-02-24 | H. Lundbeck A/S | Cyclopropyl derivatives as nk3 receptor antagonists |
EA009477B1 (ru) * | 2003-08-15 | 2008-02-28 | Х. Лундбекк А/С | Производные циклопропила в качестве антагонистов рецептора nk3 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2738819B1 (fr) * | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
US20020099076A1 (en) * | 2000-05-25 | 2002-07-25 | Richard Scheyer D. | Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis |
FR2873373B1 (fr) * | 2004-07-23 | 2006-09-08 | Sanofi Synthelabo | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique |
KR20080098070A (ko) * | 2006-02-22 | 2008-11-06 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린성 수용체의 조절제로서의 스피로 축합된 피페리딘 |
WO2010008446A2 (en) * | 2008-06-25 | 2010-01-21 | Ip Dynamics, Llc | Moisture resistant solar panel and method of making same |
EP2391615B1 (en) * | 2009-01-30 | 2013-01-16 | F. Hoffmann-La Roche AG | Piperidine derivatives as nk3 receptor antagonists |
WO2021030335A1 (en) * | 2019-08-12 | 2021-02-18 | Millendo Therapeutics, Inc. | A stereoisomerically pure nk-3 receptor antagonist and crystalline forms thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0428434A2 (fr) * | 1989-11-06 | 1991-05-22 | Sanofi | Composés aromatiques aminés et leurs énantiomères, procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0474561A1 (fr) * | 1990-09-05 | 1992-03-11 | Sanofi | Arylalkylamines, procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0512901A1 (fr) * | 1991-05-03 | 1992-11-11 | Sanofi | Composés polycycliques aminés et leurs énantiomères, procédé pour leur préparation et compositions pharmaceutiques en contenant |
EP0515240A1 (fr) * | 1991-05-03 | 1992-11-25 | Sanofi | Nouveaux composés N-alkylènepipéridino et leurs énantiomères, procédé pour leur préparation et compositions pharmaceutiques les contenant |
WO1993018002A1 (fr) * | 1992-03-03 | 1993-09-16 | Elf Sanofi | Sels quaternaires de piperidines 4-substitues, leur preparation et compositions pharmaceutiques les contenant |
EP0625509A1 (en) * | 1993-05-17 | 1994-11-23 | Zeneca Limited | N-alkyl substituted piperidine-derivatives with neurokinin receptor antagonist activity |
WO1994026735A1 (en) * | 1993-05-06 | 1994-11-24 | Merrell Dow Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
EP0673928A1 (fr) * | 1994-03-18 | 1995-09-27 | Sanofi | Nouveaux dérivés de la N-(3,4-dichlorophényl-propyl)-pipéridine comme antagonistes sélectifs du récepteur NK3 humain |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5563133A (en) * | 1995-02-21 | 1996-10-08 | Eli Lilly And Company | Hexamethyleneiminyl tachykinin receptor antagonists |
FR2738819B1 (fr) * | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
-
1995
- 1995-09-14 FR FR9510776A patent/FR2738819B1/fr not_active Expired - Fee Related
-
1996
- 1996-09-13 WO PCT/FR1996/001416 patent/WO1997010211A1/fr active IP Right Grant
- 1996-09-13 MX MX9801890A patent/MX9801890A/es not_active IP Right Cessation
- 1996-09-13 AU AU69925/96A patent/AU6992596A/en not_active Abandoned
- 1996-09-13 US US09/043,247 patent/US6028082A/en not_active Expired - Fee Related
- 1996-09-13 EP EP96931126A patent/EP1019373B1/fr not_active Expired - Lifetime
- 1996-09-13 BR BR9610081A patent/BR9610081A/pt not_active Application Discontinuation
- 1996-09-13 JP JP9511718A patent/JPH11514983A/ja active Pending
- 1996-09-13 EP EP02010824A patent/EP1241168A1/fr not_active Withdrawn
- 1996-09-13 CA CA002232007A patent/CA2232007A1/en not_active Abandoned
- 1996-09-13 AT AT96931126T patent/ATE254104T1/de not_active IP Right Cessation
- 1996-09-13 DE DE69630717T patent/DE69630717T2/de not_active Expired - Fee Related
-
1999
- 1999-11-09 US US09/437,203 patent/US6291672B1/en not_active Expired - Fee Related
-
2001
- 2001-09-18 US US09/954,862 patent/US6710042B2/en not_active Expired - Fee Related
-
2004
- 2004-03-22 US US10/805,733 patent/US20040220223A1/en not_active Abandoned
-
2007
- 2007-11-15 JP JP2007296689A patent/JP2008115182A/ja not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0428434A2 (fr) * | 1989-11-06 | 1991-05-22 | Sanofi | Composés aromatiques aminés et leurs énantiomères, procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0474561A1 (fr) * | 1990-09-05 | 1992-03-11 | Sanofi | Arylalkylamines, procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0512901A1 (fr) * | 1991-05-03 | 1992-11-11 | Sanofi | Composés polycycliques aminés et leurs énantiomères, procédé pour leur préparation et compositions pharmaceutiques en contenant |
EP0515240A1 (fr) * | 1991-05-03 | 1992-11-25 | Sanofi | Nouveaux composés N-alkylènepipéridino et leurs énantiomères, procédé pour leur préparation et compositions pharmaceutiques les contenant |
WO1993018002A1 (fr) * | 1992-03-03 | 1993-09-16 | Elf Sanofi | Sels quaternaires de piperidines 4-substitues, leur preparation et compositions pharmaceutiques les contenant |
WO1994026735A1 (en) * | 1993-05-06 | 1994-11-24 | Merrell Dow Pharmaceuticals Inc. | Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
EP0625509A1 (en) * | 1993-05-17 | 1994-11-23 | Zeneca Limited | N-alkyl substituted piperidine-derivatives with neurokinin receptor antagonist activity |
EP0673928A1 (fr) * | 1994-03-18 | 1995-09-27 | Sanofi | Nouveaux dérivés de la N-(3,4-dichlorophényl-propyl)-pipéridine comme antagonistes sélectifs du récepteur NK3 humain |
Non-Patent Citations (3)
Title |
---|
CHEMICAL ABSTRACTS, vol. 123, no. 11, 11 September 1995, Columbus, Ohio, US; abstract no. 132661j, XP002005530 * |
F. OURY-DONAT ET AL., J. PHARMACOL. EXP. THER., vol. 274, no. 1, 1995, pages 148 - 154 * |
X. EMONDS-ALT ET AL., LIFE SCIENCES, vol. 56, no. 1, 1995, pages PL27 - 32, XP002005529 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998011090A3 (en) * | 1996-09-16 | 1998-05-22 | Warner Lambert Co | 3-alkyl-3-phenyl-piperidines |
US6040316A (en) * | 1996-09-16 | 2000-03-21 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
WO1998011090A2 (en) * | 1996-09-16 | 1998-03-19 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
US6602886B2 (en) | 1996-09-16 | 2003-08-05 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
WO1998031364A1 (en) * | 1997-01-21 | 1998-07-23 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
US6124319A (en) * | 1997-01-21 | 2000-09-26 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
US6140349A (en) * | 1998-02-02 | 2000-10-31 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
WO1999038514A1 (en) * | 1998-02-02 | 1999-08-05 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
US6476054B1 (en) | 1998-02-02 | 2002-11-05 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
EP0992493A1 (en) * | 1998-10-08 | 2000-04-12 | Pfizer Inc. | Substituted benzoylpiperidine derivatives and their use as Neurokinin antagonists |
WO2000021931A1 (fr) * | 1998-10-09 | 2000-04-20 | Sanofi-Synthelabo | Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk3 humains |
US6465489B1 (en) | 1998-10-09 | 2002-10-15 | Sanofi-Synthelabo | Ureidopiperidine derivatives as selective human NK3 receptor antagonists |
WO2000035879A1 (fr) * | 1998-12-15 | 2000-06-22 | Sanofi-Synthelabo | Derives de 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide et leur procede de preparation |
US6342607B1 (en) | 1998-12-15 | 2002-01-29 | Sanofi-Synthelabo | 3-phenyl-2, 6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same |
US6452012B1 (en) | 1998-12-15 | 2002-09-17 | Sanofi-Synthelabo | 3-phenyl-2,6-dioxopiperidin-3-ylpropionamide derivatives and method for preparing same |
US6392039B1 (en) | 1998-12-23 | 2002-05-21 | Sanofi-Synthelabo | Method for preparing (R)-(+)-3 {1-[2-(4-benzoyl-2(3, 4-difluorophenyl)morpholin-2-yl)ethyl]-4-phenylpiperidin-4-yl}-1,1-dimethylurea, its salts solvates and/or hydrates |
WO2000039126A1 (fr) * | 1998-12-23 | 2000-07-06 | Sanofi-Synthelabo | Procede de preparation du (r)- (+)-3-{1-[2- (4-benzoyl-2- (3,4-difluorophenyl)morpholin-2- yl)ethyl]-4-phenylpiperidin-4- yl}-1,1- dimethyluree, de ses sels, solvats et/ou hydrates |
WO2000061125A3 (fr) * | 1999-04-13 | 2001-04-19 | Sanofi Synthelabo | L'osanetant dans le traitement des troubles de l'humeur |
US6420388B1 (en) | 1999-04-13 | 2002-07-16 | Sanofi-Synthelabo | Osanetant in the treatment of depression and depressive disorders |
WO2000061125A2 (fr) * | 1999-04-13 | 2000-10-19 | Sanofi-Synthelabo | L'osanetant dans le traitement des troubles de l'humeur |
FR2824828A1 (fr) * | 2001-05-21 | 2002-11-22 | Sanofi Synthelabo | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
WO2002094821A1 (fr) * | 2001-05-21 | 2002-11-28 | Sanofi-Synthelabo | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
WO2005016884A1 (en) | 2003-08-15 | 2005-02-24 | H. Lundbeck A/S | Cyclopropyl derivatives as nk3 receptor antagonists |
EA009477B1 (ru) * | 2003-08-15 | 2008-02-28 | Х. Лундбекк А/С | Производные циклопропила в качестве антагонистов рецептора nk3 |
AU2004265020B2 (en) * | 2003-08-15 | 2009-07-16 | H. Lundbeck A/S | Cyclopropyl derivatives as NK3 receptor antagonists |
AU2004265020B8 (en) * | 2003-08-15 | 2009-11-05 | H. Lundbeck A/S | Cyclopropyl derivatives as NK3 receptor antagonists |
US7834008B2 (en) | 2003-08-15 | 2010-11-16 | H. Lundbeck A/S | Cyclopropyl derivatives as NK3 receptor antagonists |
Also Published As
Publication number | Publication date |
---|---|
AU6992596A (en) | 1997-04-01 |
JPH11514983A (ja) | 1999-12-21 |
MX9801890A (es) | 1998-05-31 |
ATE254104T1 (de) | 2003-11-15 |
FR2738819A1 (fr) | 1997-03-21 |
EP1019373B1 (fr) | 2003-11-12 |
US20020049329A1 (en) | 2002-04-25 |
EP1019373A1 (fr) | 2000-07-19 |
US6028082A (en) | 2000-02-22 |
FR2738819B1 (fr) | 1997-12-05 |
JP2008115182A (ja) | 2008-05-22 |
DE69630717D1 (de) | 2003-12-18 |
BR9610081A (pt) | 1999-01-05 |
US6291672B1 (en) | 2001-09-18 |
DE69630717T2 (de) | 2004-09-23 |
EP1241168A1 (fr) | 2002-09-18 |
US6710042B2 (en) | 2004-03-23 |
CA2232007A1 (en) | 1997-03-20 |
US20040220223A1 (en) | 2004-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1156049B1 (fr) | Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
WO1997010211A1 (fr) | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant | |
EP0673928B1 (fr) | Nouveaux dérivés de la N-(3,4-dichlorophényl-propyl)-pipéridine comme antagonistes sélectifs du récepteur NK3 humain | |
JP3242980B2 (ja) | ポリサイクリックアミン化合物、そのエナンショマー、その製造方法、およびこれらを含有する薬剤組成物 | |
WO1995026338A1 (fr) | Antagonistes des recepteurs des neurokinines | |
US5965580A (en) | Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them | |
EP0700382A1 (fr) | Nouveaux amides n-arylaliphatiques-n-alkyl-fonctionnalises, procede pour leur preparation et compositions pharmaceutiques en contenant | |
EP1395582B1 (fr) | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant | |
WO2000021931A1 (fr) | Derives d'ureidopiperidine comme antagonistes selectifs des recepteurs nk3 humains | |
FR2755133A1 (fr) | Nouveaux derives d'amides cycliques diversement substitues antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant | |
FR2729952A1 (fr) | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant | |
WO1998004561A1 (fr) | Derives de 1-azoniabicyclo[2.2.1]heptane et compositions pharmaceutiques les contenant | |
FR2717478A1 (fr) | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. | |
FR2717477A1 (fr) | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1998/001890 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2232007 Country of ref document: CA Ref country code: CA Ref document number: 2232007 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09043247 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996931126 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1997 511718 Kind code of ref document: A Format of ref document f/p: F |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1996931126 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996931126 Country of ref document: EP |